Molecular classification of cutaneous malignant melanoma by gene expression profiling - PubMed (original) (raw)
. 2000 Aug 3;406(6795):536-40.
doi: 10.1038/35020115.
P Meltzer, Y Chen, Y Jiang, E Seftor, M Hendrix, M Radmacher, R Simon, Z Yakhini, A Ben-Dor, N Sampas, E Dougherty, E Wang, F Marincola, C Gooden, J Lueders, A Glatfelter, P Pollock, J Carpten, E Gillanders, D Leja, K Dietrich, C Beaudry, M Berens, D Alberts, V Sondak
Affiliations
- PMID: 10952317
- DOI: 10.1038/35020115
Free article
Molecular classification of cutaneous malignant melanoma by gene expression profiling
M Bittner et al. Nature. 2000.
Free article
Abstract
The most common human cancers are malignant neoplasms of the skin. Incidence of cutaneous melanoma is rising especially steeply, with minimal progress in non-surgical treatment of advanced disease. Despite significant effort to identify independent predictors of melanoma outcome, no accepted histopathological, molecular or immunohistochemical marker defines subsets of this neoplasm. Accordingly, though melanoma is thought to present with different 'taxonomic' forms, these are considered part of a continuous spectrum rather than discrete entities. Here we report the discovery of a subset of melanomas identified by mathematical analysis of gene expression in a series of samples. Remarkably, many genes underlying the classification of this subset are differentially regulated in invasive melanomas that form primitive tubular networks in vitro, a feature of some highly aggressive metastatic melanomas. Global transcript analysis can identify unrecognized subtypes of cutaneous melanoma and predict experimentally verifiable phenotypic characteristics that may be of importance to disease progression.
Similar articles
- Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
Griewank KG, Koelsche C, van de Nes JAP, Schrimpf D, Gessi M, Möller I, Sucker A, Scolyer RA, Buckland ME, Murali R, Pietsch T, von Deimling A, Schadendorf D. Griewank KG, et al. Clin Cancer Res. 2018 Sep 15;24(18):4494-4504. doi: 10.1158/1078-0432.CCR-18-0763. Epub 2018 Jun 11. Clin Cancer Res. 2018. PMID: 29891723 - Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death.
Onken MD, Worley LA, Ehlers JP, Harbour JW. Onken MD, et al. Cancer Res. 2004 Oct 15;64(20):7205-9. doi: 10.1158/0008-5472.CAN-04-1750. Cancer Res. 2004. PMID: 15492234 Free PMC article. - Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities.
Tschentscher F, Hüsing J, Hölter T, Kruse E, Dresen IG, Jöckel KH, Anastassiou G, Schilling H, Bornfeld N, Horsthemke B, Lohmann DR, Zeschnigk M. Tschentscher F, et al. Cancer Res. 2003 May 15;63(10):2578-84. Cancer Res. 2003. PMID: 12750282 - The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway.
Elder DE, Bastian BC, Cree IA, Massi D, Scolyer RA. Elder DE, et al. Arch Pathol Lab Med. 2020 Apr;144(4):500-522. doi: 10.5858/arpa.2019-0561-RA. Epub 2020 Feb 14. Arch Pathol Lab Med. 2020. PMID: 32057276 Review. - Focus on cutaneous and uveal melanoma specificities.
Pandiani C, Béranger GE, Leclerc J, Ballotti R, Bertolotto C. Pandiani C, et al. Genes Dev. 2017 Apr 15;31(8):724-743. doi: 10.1101/gad.296962.117. Genes Dev. 2017. PMID: 28512236 Free PMC article. Review.
Cited by
- Higher Nodal expression is often associated with poorer survival in patients diagnosed with melanoma and treated with anti-PD1 therapy.
Gascard PD, Wang X, Nosrati M, Kim KB, Kashani-Sabet M, Tlsty TD, Leong SP, Hendrix MJC. Gascard PD, et al. Pathol Oncol Res. 2024 Sep 23;30:1611889. doi: 10.3389/pore.2024.1611889. eCollection 2024. Pathol Oncol Res. 2024. PMID: 39376672 Free PMC article. - Insights into the Gene Expression Profile of Classical Hodgkin Lymphoma: A Study towards Discovery of Novel Therapeutic Targets.
Aloliqi AA. Aloliqi AA. Molecules. 2024 Jul 25;29(15):3476. doi: 10.3390/molecules29153476. Molecules. 2024. PMID: 39124881 Free PMC article. - A developmental constraint model of cancer cell states and tumor heterogeneity.
Patel AS, Yanai I. Patel AS, et al. Cell. 2024 Jun 6;187(12):2907-2918. doi: 10.1016/j.cell.2024.04.032. Cell. 2024. PMID: 38848676 Review. - Endothelin and the tumor microenvironment: a finger in every pie.
Arndt PF, Turkowski K, Cekay MJ, Eul B, Grimminger F, Savai R. Arndt PF, et al. Clin Sci (Lond). 2024 Jun 5;138(11):617-634. doi: 10.1042/CS20240426. Clin Sci (Lond). 2024. PMID: 38785410 Free PMC article. Review. - Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance.
Bhat GR, Sethi I, Sadida HQ, Rah B, Mir R, Algehainy N, Albalawi IA, Masoodi T, Subbaraj GK, Jamal F, Singh M, Kumar R, Macha MA, Uddin S, Akil ASA, Haris M, Bhat AA. Bhat GR, et al. Cancer Metastasis Rev. 2024 Mar;43(1):197-228. doi: 10.1007/s10555-024-10172-z. Epub 2024 Feb 8. Cancer Metastasis Rev. 2024. PMID: 38329598 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials